Vanda Pharmaceuticals News
Most Popular Vanda Pharmaceuticals Story
Analysts: Vanda Pharma ripe for buyout
Two months after winning regulatory approval for a new schizophrenia therapy, analysts say that Vanda Pharmaceuticals is too weak financially to launch the drug by itself, leaving the developer ripe Read more...
Latest Headlines
- October 16, 2009
- October 13, 2009
- July 23, 2009
- February 25, 2009
- October 31, 2008
- July 28, 2008
- June 26, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
